Who owns XTL BIOPHARMACEUTICALS LTD SPONSORED ADS?
- Ticker: XTLB
- CUSIP Number: 98386d406
Tip: Access positions for across all investors
Analyze quarterly positions in Xtl Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xtl Biopharmaceuticals stock
Who bought or sold XTL BIOPHARMACEUTICALS LTD SPONSORED ADS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Noked Israel | 50k | $120k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 6.0k | $14k | 100% | Mar 2026 |
|
| GAMMA Investing | 1.2k | $3.3k | -64% | Jun 2026 |
|
| Tower Research Capital | 244.00 | $587.991200 | 100% | Mar 2026 |
|
| Morgan Stanley | 10.00 | $24.000000 | 100% | Mar 2026 |
|
Who sold out of Xtl Biopharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| SmartHarvest Portfolios | Mar 2026 | 13k | $32k |